This is the classic website, which will be retired eventually. Please visit the modernized instead.
Working… Menu

Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease (ABCVILD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04925375
Recruitment Status : Recruiting
First Posted : June 14, 2021
Last Update Posted : November 7, 2023
Bristol-Myers Squibb
Information provided by (Responsible Party):
Children's Hospital Medical Center, Cincinnati

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : July 2025
Estimated Study Completion Date : July 2025